The Latest Breaking News from BioTechne

RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, creating an attractive entry point.

Bio-Techne has notably underperformed the broader market over the past year, and analysts remain cautiously optimistic about the stock’s prospects.

Bio-Techne has underperformed the healthcare sector over the past year, yet analysts remain strongly bullish about the stock’s prospects.

Bio-Techne has underperformed the broader market this year, but Wall Street analysts are optimistic about the stock’s prospects.

With Bio-Techne gearing up to release its fourth-quarter earnings next month, analysts project a double-digit earnings decline.

Small-cap stocks frequently hold untapped potential. Here are three high-quality small-cap stocks that investors might be overlooking.

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.70%. US stock indexes Wednesday settled mixed. Stock prices whipsawed higher Wednesday afternoon after bond...

The S&P 500 Index ($SPX ) (SPY ) is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. The market is mixed the FOMC was released this afternoon. Chairman Jerome Powell announce no...

The S&P 500 Index ($SPX ) (SPY ) is up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. The FOMC was released this afternoon . Chairman Jerome Powell announced no change in the...